Correlation Between Neximmune and Orgenesis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neximmune and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Orgenesis, you can compare the effects of market volatilities on Neximmune and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Orgenesis.

Diversification Opportunities for Neximmune and Orgenesis

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Neximmune and Orgenesis is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Neximmune i.e., Neximmune and Orgenesis go up and down completely randomly.

Pair Corralation between Neximmune and Orgenesis

Given the investment horizon of 90 days Neximmune is expected to generate 1.9 times more return on investment than Orgenesis. However, Neximmune is 1.9 times more volatile than Orgenesis. It trades about 0.03 of its potential returns per unit of risk. Orgenesis is currently generating about -0.13 per unit of risk. If you would invest  280.00  in Neximmune on September 22, 2024 and sell it today you would lose (37.00) from holding Neximmune or give up 13.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy19.77%
ValuesDaily Returns

Neximmune  vs.  Orgenesis

 Performance 
       Timeline  
Neximmune 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Orgenesis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neximmune and Orgenesis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neximmune and Orgenesis

The main advantage of trading using opposite Neximmune and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.
The idea behind Neximmune and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital